2025-09-28 - Analysis Report
Okay, here's an analysis of Honeywell International Inc. (HON) based on the data provided.

## Honeywell International Inc. (HON) Analysis

Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products, building and industrial control technologies, and performance materials.

### 1. Performance vs. S&P 500 (VOO)

*   **HON Cumulative Return:** 8.17%
*   **VOO Cumulative Return:** 66.41%
*   **Absolute Divergence:** -81.9%
*   **Relative Divergence:** 1.3% (min: -83.1, max: 7.3)

**Analysis:** HON has significantly underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence indicates HON is currently near its historical low compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|--------|--------|------|--------|
| 2015-2017  | 30.0%   | 66.2%  | 21.0%  | -0.0 | 93.3   |
| 2016-2018  | 22.0%   | 70.4%  | 23.0%  | 0.0  | 83.9   |
| 2017-2019  | 40.0%   | 71.1%  | 35.0%  | 0.1  | 112.4  |
| 2018-2020  | 9.0%    | 79.6%  | -16.0% | 0.1  | 135.0  |
| 2019-2021  | 14.0%   | 79.6%  | -15.0% | 0.5  | 132.4  |
| 2020-2022  | 2.0%    | 79.6%  | -12.0% | 0.5  | 136.1  |
| 2021-2023  | -5.0%   | 77.9%  | -23.0% | 0.9  | 133.1  |
| 2022-2024  | -11.0%  | 79.6%  | -23.0% | 0.9  | 143.4  |
| 2023-2025  | -24.0%  | 79.6%  | -59.0% | 1.9  | 132.2  |

**Analysis:** The table shows decreasing CAGR, increasing Beta and negative Alpha recently.  This suggests HON's performance has worsened relative to the market, and it has become more volatile and its returns are not compensating for the risk.

### 2. Recent Price Action

*   **Current Price:** 208.19
*   **Previous Close:** 207.60
*   **Change:** 0.28
*   **5-day Moving Average:** 208.55
*   **20-day Moving Average:** 212.06
*   **60-day Moving Average:** 221.41

**Analysis:** The current price is slightly up from the previous close. The price is below all three moving averages, suggesting a short-term downward trend. The fact the current price is only slightly above the previous close suggests no major price volatility.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 31.03 (Approaching Oversold)
*   **PPO:** -0.0697
*   **Delta_Previous_Relative_Divergence:** 1.3 (Short-term increase)
*   **Expected Return:** -2599.6%

**Analysis:**

*   The MRI suggests a high investment recommendation, indicating the model views the stock as relatively safe despite market conditions.
*   The RSI is approaching oversold territory (below 30), which could signal a potential buying opportunity if you believe the stock is undervalued.
*   The PPO is negative, indicating that the short-term moving average is below the long-term moving average.
*   The positive Delta_Previous_Relative_Divergence suggests a recent short-term increase in relative performance, but starting from a very low base.
*   The negative expected return suggests the model predicts poor long-term (2+ years) relative performance compared to the S&P 500 if you invest today.

### 4. Recent News & Significant Events

*   **UBS Reiterates Buy Rating:** A positive signal from a major investment bank.
*   **Fresh Look at Valuation:** Indicates that the recent share price cooling warrants a re-evaluation.
*   **Institutional Ownership:** High institutional ownership can provide stability but also makes the stock vulnerable to large sell-offs if sentiment changes.
*   **Delta Fixes Airbus Jets:** This could involve Honeywell products and services, potentially having a positive impact.
*   **Honeywell to Increase Dividend:** Positive news for investors seeking income.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (1.96 on a 1-5 scale)
*   **Target Price:** Average $252.97 (Upside potential)
*   **Recent Rating Changes:** No recent changes reported

**Analysis:** Analyst consensus is generally positive, with a "Buy" rating and a target price significantly above the current price.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-07-24 | 2.46  | 10.35 B$  |
| 2025-04-29 | 2.24  | 9.82 B$   |
| 2024-10-24 | 2.17  | 9.73 B$   |
| 2024-07-25 | 2.37  | 9.58 B$   |
| 2025-07-24 | 2.37  | 9.58 B$   |

**Analysis:** Recent EPS and revenue figures show a generally positive trend, with slight increases in both EPS and revenue over the past few quarters.

### 6. Financial Information

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $10.35B    | 38.86%        |
| 2025-03-31 | $9.82B     | 38.54%        |
| 2024-12-31 | $10.09B    | 36.38%        |
| 2024-09-30 | $9.73B     | 38.54%        |
| 2024-06-30 | $9.58B     | 38.85%        |

| Quarter    | Equity      | ROE      |
|------------|-------------|----------|
| 2025-06-30 | $16.09B     | 9.75%    |
| 2025-03-31 | $17.46B     | 8.30%    |
| 2024-12-31 | $18.62B     | 6.90%    |
| 2024-09-30 | $17.41B     | 8.12%    |
| 2024-06-30 | $16.95B     | 9.11%    |

**Analysis:**

*   Revenue is showing a slight upward trend.
*   Profit margins have remained relatively stable.
*   Equity has fluctuated, and ROE has also varied.

### 7. Summary

HON has significantly underperformed the S&P 500. Recent price action is slightly positive, but the stock is trading below its moving averages. Technical indicators suggest it is approaching oversold conditions, while the MRI still recommends a high investment. Analyst consensus is generally positive, with a buy rating and a target price significantly above the current price. Recent earnings and financial data show a generally positive trend, with slight increases in both EPS and revenue over the past few quarters and stable profit margins. The upcoming dividend increase is a positive factor.

**Overall:** While HON's historical performance compared to the S&P 500 is concerning, analysts' positive outlook and recent positive news warrant further investigation. The stock might be undervalued, but the negative expected return should be considered carefully.
